Join to view full profile
1100 Fairview Ave N, D3-190Seattle, WA 98109
Dr. Orozco is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2009 - 2012
University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
University of Washington School of MedicineClass of 2006
University of WashingtonPhD, Bioengineering, 1999 - 2004
Certifications & Licensure
CA State Medical License 2008 - Present
WA State Medical License 2009 - 2028
American Board of Internal Medicine Hematology
Clinical Trials
Publications & Presentations
PubMed
- First-In-Human Study ofAt-CD45 Radioimmunotherapy With Nonmyeloablative Conditioning Hematopoietic Cell Transplantation for Adults With Hematologic Malignancies.Phuong T Vo, Roland B Walter, Ted A Gooley, Donald K Hamlin, Robyn Haaf
Journal of Clinical Oncology. 2026-10-15 - CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.Shyril O'Steen, Sang Y Lee, Melissa L Comstock, Allie R Kehret, Yukang Lin
Journal of Nuclear Medicine. 2026-05-01 - 1 citationsThe bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.Matthew W Hagen, Nicollette J Setiawan, Shannon Dexter, Kelsey A Woodruff, Francesca K Gaerlan
Blood Advances. 2026-04-14
Journal Articles
- Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G-CSF with Dose-Escalated Mitoxantrone for relapsed/refractory Acute Myeloid Leukemia or Other H...Kelda M Gardner, Vivian G Oehler, Heather A Smith, Anna B Halpern, Paul C Hendrie, Sarah A Buckley, Roland B Walter, Pamela S Becker, Ryan D Cassaday, Asma Anwar, Bart..., Haematologica
Abstracts/Posters
- Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...Johnnie Orozco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...Johnnie Orozco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µci/Kg/Dose2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
$3.4 Million Grant to Find Safer, More Effective Leukemia TreatmentsJuly 27th, 2020
Grant Support
- Combining Targeted RIT and Synergistic Novel Agent-RenewalFRED HUTCHINSON CANCER CENTER2020–2027
- Selective Radionuclide Delivery for Precise Bone Marrow Niche AlterationsFRED HUTCHINSON CANCER CENTER2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
